Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1025 - 1032 of 12065 results

Northeastern Law Magazine Profiles Member Drew DeVoogd
March 9, 2024| News

How IP Lawyers Are Meeting Clients’ Patent Licensing Needs
March 8, 2024| News

Health Law Diagnosed – A Discussion on the Regulatory Requirements for LDTs
March 7, 2024| Podcast| Viewpoint

DOJ and FTC Weigh in on Alleged Algorithmic Price Fixing — AI: The Washington Report
March 7, 2024| Article| Viewpoint

How Can the Updated USPTO Guidance on Determining Obviousness Help You?
March 7, 2024| Blog| Viewpoint

FTC Hosts Panel and Launches Public Inquiry with DOJ and HHS on Private Equity and Health Care
March 6, 2024| Advisory| Viewpoint

What’s New in Wireless - March 2024
March 6, 2024| Blog| Viewpoint

Tips For Counsel Seeking Balance In The ESG Political Divide
March 6, 2024| News
News & Press Releases
Mintz Advises PHLUR on Acquisition by TSG Consumer
July 29, 2025
Mintz advised PHLUR, a modern fragrance brand recognized for its emotion-led storytelling and accessible positioning, in its acquisition by TSG Consumer, a leading private equity firm specializing in consumer brands.
Mintz Attorneys Named to Los Angeles Business Journal’s 2025 “Leaders of Influence: Litigators & Trial Attorneys” List
July 28, 2025
Mintz Member Esteban Moralesand Special Counsel Nada Shamonki has been recognized by Los Angeles Business Journal in its 2025 “Leaders of Influence: Litigators & Trial Attorneys” list which recognizes lawyers who “go to the proverbial mat to fight for their clients,” according to the publication.
Is Biopharma M&A In a Holding Pattern or a ‘New Normal’
July 23, 2025
Life Sciences International Chair Cheryl Reicin recently joined the Scrip M&A Podcast to share insights on the evolving landscape of biopharmaceutical mergers and acquisitions. In the episode, Cheryl highlights an uptick in pre-M&A activity, as major pharmaceutical companies increasingly leverage license and option agreements to strengthen their pipelines and product portfolios while positioning themselves for potential future acquisitions.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
